Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

February 4, 2010

Primary Completion Date

October 10, 2011

Study Completion Date

December 31, 2025

Conditions
Ovarian Cancer
Interventions
DRUG

olaparib

Tablets Oral BID

DRUG

paclitaxel

175mg/m2 iv for 6 cycles (18 weeks) day 1 of 21 day cycle

DRUG

carboplatin

AUC6 iv for 6 cycles (18 weeks) day 1 of 21 day cycle

DRUG

paclitaxel

175mg/m2 iv for up to 6 cycles (18 weeks)

DRUG

Drug: carboplatin

AUC4 iv for up to 6 cycles (18 weeks)

Trial Locations (53)

1090

Research Site, Brussels

2031

Research Site, Randwick

2610

Research Site, Wilrijk

2723

Research Site, Panama City

3000

Research Site, Leuven

3050

Research Site, Parkville

5000

Research Site, Namur

10016

Research Site, New York

10126

Research Site, Torino

16132

Research Site, Genova

20052

Research Site, Monza

20141

Research Site, Milan

20246

Research Site, Hamburg

32806

Research Site, Orlando

42653

Research Site, Solingen

45147

Research Site, Essen

46010

Research Site, Valencia

46202

Research Site, Indianapolis

60590

Research Site, Frankfurt

81675

Research Site, München

90048

Research Site, West Hollywood

94305

Research Site, Stanford

02114

Research Site, Boston

02215

Research Site, Boston

97227-1191

Research Site, Portland

V5Z 4E6

Research Site, Vancouver

L8V 5C2

Research Site, Hamilton

M4N 3M5

Research Site, Toronto

M5G 2M9

Research Site, Toronto

G1R 2J6

Research Site, Québec

J1H 5N4

Research Site, Sherbrooke

625 00

Research Site, Brno

656 53

Research Site, Brno

500 05

Research Site, Hradec Králové

775 20

Research Site, Olomouc

120 00

Research Site, Prague

104-0045

Research Site, Chūōku

811-1395

Research Site, Fukuoka

791-0280

Research Site, Matsuyama

028-3695

Research Site, Morioka

160-8582

Research Site, Shinjuku-ku

990-9585

Research Site, Yamagata

683-8504

Research Site, Yonago-shi

1066 CX

Research Site, Amsterdam

1105 AZ

Research Site, Amsterdam

6525 GA

Research Site, Nijmegen

3015 GD

Research Site, Rotterdam

LIMA 27

Research Site, Lima

LIMA 41

Research Site, Lima

08035

Research Site, Madrid

B18 7QH

Research Site, Birmingham

CV2 2DX

Research Site, Coventry

EH4 2XR

Research Site, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY